Tue, Jan 27, 2015, 6:07 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • siestacottage siestacottage Jun 12, 2014 7:36 AM Flag

    The Fool Article - very very positive

    When push comes to shove, what's going to matter most is VGX-3100's mid-stage results that are set to be released at anytime. If positive, Inovio could see one of the biggest short squeezes in biotech history. So all eyes are closely watching the company's mid-stage DNA vaccine dubbed "VGX-3100," which is expected to report top-line data at any time now. In light of the diversity of diseases Inovio is targeting with its platform and the blockbuster potential of a new HPV vaccine, it's easy to understand why investors remain optimistic about the company's future. When push comes to shove, what's going to matter most is VGX-3100's mid-stage results that are set to be released at anytime. ANYTIME !!! be ready

 
INO
8.94+0.06(+0.68%)Jan 27 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.